Are selective serotonin reuptake inhibitors a secondary cause of low bone density?

Journal of Osteoporosis

Volumn 2012, Issue , 2012, Pages

  Chau, Kim ^a   Atkinson, Stephanie A ^a   Taylor, Valerie H ^b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ALGORITHM; BODY MASS; BONE DENSITY; CASE CONTROL STUDY; COHORT ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DSM-IV; DUAL ENERGY X RAY ABSORPTIOMETRY; FRACTURE; HUMAN; MEDLINE; MENOPAUSE; MENTAL DISEASE; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE; SIDE EFFECT;

EID: 84868698816     PISSN: 20908059     EISSN: 20420064     Source Type: Journal    
DOI: 10.1155/2012/323061     Document Type: Review

References (45)

1. Sawka A. M., The number of Canadian men and women needed to be screened to detect a case of osteoporosis: a population based study from the Canadian Multicentre Osteoporosis Study (CaMos). Journal of Bone Mineral Research 2004 19 S368
2. Looker A. C., Melton L. J., Harris T. B., Shepherd J. A., Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III. Journal of Bone and Mineral Research 2010 25 1 64 71 2-s2.0-77953393581 10.1359/jbmr.090706
3. Doherty D. A., Sanders K. M., Kotowicz M. A., Prince R. L., Lifetime and five-year age-specific risks of first and subsequent osteoporotic fractures in postmenopausal women. Osteoporosis International 2001 12 1 16 23 2-s2.0-0035086805 10.1007/s001980170152 (Pubitemid 32233654)
4. Cummings S. R., Blacks D. M., Rubin S. M., Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausasl women. Archives of Internal Medicine 1989 149 11 2445 2448 2-s2.0-0024440578 (Pubitemid 19283200)
5. Melton L. J., Chrischilles E. A., Cooper C., Lane A. W., Riggs B. L., Perspective: how many women have osteoporosis? Journal of Bone and Mineral Research 1992 7 9 1005 1010 2-s2.0-0026670254
6. Ioannidis G., Papaioannou A., Hopman W. M., Akhtar-Danesh N., Anastassiades T., Pickard L., Kennedy C. C., Prior J. C., Olszynski W. P., Davison K. S., Goltzman D., Thabane L., Gafni A., Papadimitropoulos E. A., Brown J. P., Josse R. G., Hanley D. A., Adachi J. D., Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. Canadian Medical Association Journal 2009 181 5 265 271 2-s2.0-70349146237 10.1503/cmaj.081720
7. Wiktorowicz M. E., Goeree R., Papaioannou A., Adachi J. D., Papadimitropoulos E., Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporosis International 2001 12 4 271 278 2-s2.0-0035554390 10.1007/s001980170116 (Pubitemid 34912733)
8. WHO, The world health report 2001: mental health: new understanding, new hope. Geneva, Switzerland, 2001
9. Taylor V., McKinnon M. C., Macdonald K., Jaswal G., MacQueen G. M., Adults with mood disorders have an increased risk profile for cardiovascular disease within the first 2 years of treatment. Canadian Journal of Psychiatry 2010 55 6 362 368 2-s2.0-77953757641
10. Mann J. J., Malone K. M., Diehl D. J., Perel J., Cooper T. B., Mintun M. A., Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. American Journal of Psychiatry 1996 153 2 174 182 2-s2.0-0030048176 (Pubitemid 26038957)
11. Raymond J. R., Mukhin Y. V., Gelasco A., Turner J., Collinsworth G., Gettys T. W., Grewal J. S., Garnovskaya M. N., Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacology and Therapeutics 2001 92 2-3 179 212 2-s2.0-0035728258 10.1016/S0163-7258(01)00169-3 (Pubitemid 34251133)
12. Murphy D. L., Lerner A., Rudnick G., Lesch K. P., Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Molecular Interventions 2004 4 2 109 123 2-s2.0-2342629856 10.1124/mi.4.2.8 (Pubitemid 38584973)
13. Rot M. A. H., Mathew S. J., Charney D. S., Neurobiological mechanisms in major depressive disorder. Canadian Medical Association Journal 2009 180 3 305 313 2-s2.0-61449197838 10.1503/cmaj.080697
14. Hubbard R., Farrington P., Smith C., Smeeth L., Tattersfield A., Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. American Journal of Epidemiology 2003 158 1 77 84 2-s2.0-0038205572 10.1093/aje/kwg114 (Pubitemid 36745333)
15. Kinjo M., Setoguchi S., Schneeweiss S., Solomon D. H., Bone mineral density in subjects using central nervous system-active medications. American Journal of Medicine 2005 118 12 1414 2-s2.0-29244460043 10.1016/j.amjmed.2005. 07.033 (Pubitemid 41832340)
16. Diem S. J., Blackwell T. L., Stone K. L., Yaffe K., Haney E. M., Bliziotes M. M., Ensrud K. E., Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Archives of Internal Medicine 2007 167 12 1240 1245 2-s2.0-34347220867 10.1001/archinte.167.12.1240 (Pubitemid 46998494)
17. Richards J. B., Papaioannou A., Adachi J. D., Joseph L., Whitson H. E., Prior J. C., Goltzman D., david.goltzman@mcgill.ca Effect of selective serotonin reuptake inhibitors on the risk of fracture. Archives of Internal Medicine 2007 167 2 188 194 10.1001/archinte.167.2.188 (Pubitemid 46148067)
18. Langer S. Z., Brunello N., Racagni G., Mendlewicz J., Serotonin Receptor Subtypes: Pharmacological Significance and Clinical Implications 1992 Basel, Switzerland Karger
19. Leonard B. E., Sub-types of serotonin receptors: biochemical changes and pharmacological consequences. International Clinical Psychopharmacology 1992 7 1 13 21 2-s2.0-0026657470
20. Heninger G. R., Bloom F. E., Kupfer D. J., Indoleamines: the role of serotonin in clinical disorders. Psycho- Pharmacology: The Fourth Generation of Progress 1995 New York, NY, USA Raven Press 471 482
21. Jacobs B. L., Fornal C. A., Bloom F. E., Kupfer D. J., Serotonin and behavior: a general hypothesis. Psychopharmacology: The Fourth Generation of Progress 1995 New York, NY, USA Raven Press 461 470
22. Stahl S. M., Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. Journal of Affective Disorders 1998 51 3 215 235 2-s2.0-0032440963 10.1016/S0165-0327(98)00221-3 (Pubitemid 29202172)
23. Bliziotes M. M., Eshleman A. J., Zhang X. W., Wiren K. M., Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake. Bone 2001 29 5 477 486 2-s2.0-0034747779 10.1016/S8756-3282(01)00593-2 (Pubitemid 33026469)
24. Westbroek I., Van der Plas A., De Rooij K. E., Klein-Nulend J., Nijweide P. J., Expression of serotonin receptors in bone. The Journal of Biological Chemistry 2001 276 31 28961 28968 2-s2.0-0035800774 10.1074/jbc.M101824200
25. Battaglino R., Fu J., Späte U., Ersoy U., Joe M., Sedaghat L., Stashenko P., Serotonin regulates osteoclast differentiation through its transporter. Journal of Bone and Mineral Research 2004 19 9 1420 1431 2-s2.0-12344334748 10.1359/JBMR.040606 (Pubitemid 41094343)
26. Warden S. J., Bliziotes M. M., Wiren K. M., Eshleman A. J., Turner C. H., Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine). Molecular and Cellular Endocrinology 2005 242 1-2 1 9 2-s2.0-25844483751 10.1016/j.mce.2005.06.005 (Pubitemid 41393704)
27. Vestergaard P., Rejnmark L., Mosekilde L., Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporosis International 2006 17 6 807 816 2-s2.0-33646871582 10.1007/s00198-005-0065-y (Pubitemid 43781493)
28. Spangler L., Scholes D., Brunner R. L., Robbins J., Reed S. D., Newton K. M., Melville J. L., Lacroix A. Z., Depressive symptoms, bone loss, and fractures in postmenopausal women. Journal of General Internal Medicine 2008 23 5 567 574 2-s2.0-42449154971 10.1007/s11606-008-0525-0
29. Yirmiya R., Bab I., Major depression is a risk factor for low bone mineral density: a meta-analysis. Biological Psychiatry 2009 66 5 423 432 2-s2.0-68049127806 10.1016/j.biopsych.2009.03.016
30. Yadav V. K., Oury F., Suda N., Liu Z. W., Gao X. B., Confavreux C., Klemenhagen K. C., Tanaka K. F., Gingrich J. A., Guo X. E., Tecott L. H., Mann J. J., Hen R., Horvath T. L., Karsenty G., A Serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 2009 138 5 976 989 2-s2.0-69449083603 10.1016/j.cell.2009.06.051
31. Michelson D., Stratakis C., Hill L., Reynolds J., Galliven E., Chrousos G., Gold P., Bone mineral density in women with depression. The New England Journal of Medicine 1996 335 16 1176 1181 2-s2.0-0029823520 10.1056/ NEJM199610173351602 (Pubitemid 26339771)
32. Cauley J. A., jcauley@pitt.edu Fullman R. L., Stone K. L., Zmuda J. M., Bauer D. C., Barrett-Connor E., Ensrud K., Lau E. M.C., Orwoll E. S., Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporosis International 2005 16 12 1525 1537 10.1007/s00198-005- 1866-8 (Pubitemid 41790856)
33. Eskandari F., Martinez P. E., Torvik S., Phillips T. M., Sternberg E. M., Mistry S., Ronsaville D., Wesley R., Toomey C., Sebring N. G., Reynolds J. C., Blackman M. R., Calis K. A., Gold P. W., Cizza G., cizzag@intra.niddk.nih.gov Low bone mass in premenopausal women with depression. Archives of Internal Medicine 2007 167 21 2329 2336 10.1001/archinte.167.21.2329 (Pubitemid 350179528)
34. Williams L. J., Henry M. J., Berk M., Dodd S., Jacka F. N., Kotowicz M. A., Nicholson G. C., Pasco J. A., Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression. International Clinical Psychopharmacology 2008 23 2 84 87 2-s2.0-39849100862 10.1097/YIC.0b013e3282f2b3bb (Pubitemid 351317280)
35. Petronijević M., Petronijević N., natasapetronijevic@yahoo. com Ivković M., Stefanović D., Radonjić N., Glišić B., Ristić G., Damjanović A., Paunović V., Low bone mineral density and high bone metabolism turnover in premenopausal women with unipolar depression. Bone 2008 42 3 582 590 10.1016/j.bone.2007.11. 010
36. Ziere G., Dieleman J. P., Van Der Cammen T. J. M., Hofman A., Pols H. A. P., Stricker B. H. C., Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. Journal of Clinical Psychopharmacology 2008 28 4 411 417 2-s2.0-54449089554 10.1097/JCP.0b013e31817e0ecb
37. Murray C. J. L., Lopez A. D., Global mortality, disability, and the contribution of risk factors: global burden of disease study. The Lancet 1997 349 9063 1436 1442 2-s2.0-0030996001 10.1016/S0140-6736(96)07495-8 (Pubitemid 27212192)
38. Williams J. W. Jr., Mulrow C. D., Chiquette E., Noël P. H., Aguilar C., Cornell J., A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Annals of Internal Medicine 2000 132 9 743 756 2-s2.0-0034595401 (Pubitemid 30244176)
39. Pirraglia P. A., Stafford R. S., Singer D. E., Trends in prescribing of selective serotonin reuptake inhibitors and other newer antidepressant agents in adult primary care. The Journal of Clinical Psychiatry, the Primary Care Companion 2003 5 4 153 157
40. Bab I. A., Yirmiya R., Depression and bone mass. Annals of the New York Academy of Sciences 2010 1192 170 175 2-s2.0-77950668547 10.1111/j.1749-6632. 2009.05218.x
41. Kavuncu V., Kuloglu M., Kaya A., Sahin S., Atmaca M., Firidin B., Bone metabolism and bone mineral density in premenopausal women with mild depression. Yonsei Medical Journal 2002 43 1 101 108 2-s2.0-0036188516 (Pubitemid 34196433)
42. Kessler R. C., Angermeyer M., Anthony J. C., De Graaf R., Demyttenaere K., Gasquet I., De Girolamo G., Guzman S., Gureje O., Haro J. M., Kawakami N., Karam A., Levinson D., Mora M. E. M., Browne M. A. O., Posada-Villa J., Stein D. J., Tsang C. H.A., Aguilar-Gaxiola S., Alonso J., Lee S., Heeringa S., Pennell B. -E., Berglund P., Gruber M. J., Petukhova M., Chatterji S., Üstün T. B., Lifetime prevalence and age-of-onset distributions of mental disorders in the world health organization's world mental health survey initiative. World Psychiatry 2007 6 3 168 176 (Pubitemid 350047829)
43. Whooley M. A., whooley@itsa.ucsf.edu Kip K. E., Cauley J. A., Ensrud K. E., Nevitt M. C., Browner W. S., Depression, falls, and risk of fracture in older women. Archives of Internal Medicine 1999 159 5 484 490 10.1001/archinte.159.5.484 (Pubitemid 29108914)
44. Liu B., Anderson G., Mittmann N., To T., Axcell T., Shear N., Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. The Lancet 1998 351 9112 1303 1307 2-s2.0-0032474241 10.1016/S0140-6736(97)09528-7 (Pubitemid 28195906)
45. Haney E. M., Chan B. K. S., Diem S. J., Ensrud K. E., Cauley J. A., Barrett-Connor E., Orwoll E., Bliziotes M. M., Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Archives of Internal Medicine 2007 167 12 1246 1251 2-s2.0-34347262073 10.1001/archinte.167.12.1246 (Pubitemid 46998495)